Calix (CALX) Earnings Analysis
Calix (CALX) next reports earnings on 2026-11-04, consensus EPS 0.4114 USD. Last quarter (2026-07-20) it beat with EPS 0.47 USD vs 0.4048 USD est (+16.1%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E 45.37.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CALX next report earnings?
| Next earnings date | 2026-11-04 |
|---|---|
| Consensus EPS estimate | 0.4114 USD |
| Revenue estimate | 0.30B |
CALX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-20 | 0.47 USD | 0.4048 USD | +16.1% | Beat |
| 2026-01-28 | 0.39 USD | 0.38 USD | +2.6% | Beat |
| 2025-07-21 | 0.33 USD | 0.2 USD | +65% | Beat |
| 2025-04-21 | 0.19 USD | 0.13 USD | +46.2% | Beat |
| 2025-01-29 | 0.08 USD | 0.07 USD | +14.3% | Beat |
| 2024-10-28 | 0.13 USD | 0.09 USD | +44.4% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
CALX valuation and analyst view
| Trailing P/E | 45.37 |
|---|---|
| Trailing EPS | 0.80595 USD |
| Price / book | 3.21 |
| Dividend yield | 0.00% |
| Market cap | 2.29B |
| Analyst consensus | Buy (15 buy / 5 hold / 1 sell) |
| Avg price target | 52 USD |
Related research pages
Frequently asked questions
When is Calix (CALX)'s next earnings date?
Calix is next scheduled to report on 2026-11-04, with a consensus EPS estimate of 0.4114 USD and revenue estimate of 0.30B.
Did CALX beat earnings last quarter?
In its 2026-07-20 report, CALX posted EPS of 0.47 USD versus a 0.4048 USD estimate — a beat of 16.1%.
What is CALX's earnings track record?
Over the last 6 reported quarters with consensus data, CALX beat estimates 6 times (100%).
What is CALX's current P/E ratio and EPS?
CALX trades at a trailing P/E of 45.37 on trailing EPS of 0.8059544051892437 USD.
What do analysts rate CALX?
Analyst consensus is "Buy" across 21 ratings (0 strong buy, 15 buy, 5 hold, 1 sell, 0 strong sell). Average 12-month price target: 52 USD.